Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (NYSE:RHE) (NYSE:RHE) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into a definitive agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of 1,410,000 shares of Regional common stock and 1,410,000 shares of Regional's newly-authorized Series D 8% C

SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2024 compared to a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for the first fiscal quarter ended September 30, 2023. During the quarter ended September 30, 2024, the Company sold non-core assets for cash totaling $1,465,000, which resulted in an aggregate pre-tax gain of $694,000 in the quarter ended September 30, 2024. Net loss for the quarter ended September 30, 2024 was $549,000 (or a loss of $0.08 per fully diluted share) compared to a net loss of

SunLink Health Systems, Inc. (NYSE:SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., and an affiliate, have completed the sale of the hospital building and related real estate of its formerly operated Trace Regional Hospital in Houston, Mississippi for approximately $2,000,000. The company said the net proceeds of approximately $1,932,000 will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax loss on the sale of approximately $91,000 in its second fiscal quarter ending December 31, 2024. SunLink noted that the sale is intended to further its strategy of positioning itself for the possibility of a

SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $652,000 (or a loss of $0.09 per fully diluted share) for its fourth fiscal quarter ended June 30, 2024 compared to a loss from continuing operations of $1,021,000 (or a loss of $0.15 per fully diluted share) for the fourth fiscal quarter ended June 30, 2023. Earnings from discontinued operations were $4,940,000 (or earnings of $0.70 per fully diluted share) for the fourth fiscal quarter ended June 30, 2024 compared to a loss from discontinued operations of $405,000 (or a loss of $0.06 per fully diluted share) for the fourth fiscal quarter ended June 30, 2023. During the quarter ended June 30, 2024

SunLink Health Systems, Inc. (NYSE:AMERICAN) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., has completed the sale of its Trace Extended Care & Rehab senior care facility and related real estate in Houston, Mississippi for approximately $7,100,000. The company said the net proceeds of approximately $6,500,000 will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax gain on the sale of approximately $5,700,000 in its fourth fiscal quarter ending June 30, 2024. SunLink noted that the sale is intended to further its strategy of positioning itself for an extraordinary transaction, which might include a

SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for its third fiscal quarter ended March 31, 2024 compared to a loss from continuing operations of $453,000 (or a loss of $0.06 per fully diluted share) for the third fiscal quarter ended March 31, 2023. Net loss for the quarter ended March 31, 2024 was $1,396,000 (or a loss of $0.20 per fully diluted share) compared to a net loss of $762,000 (or a loss of $0.11 per fully diluted share) for the quarter ended March 31, 2023. The net loss for the third fiscal quarter of 2024 included a loss from discontinued operations of $572,000 (or a loss of $

SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for its second fiscal quarter ended December 31, 2023 compared to earnings from continuing operations of $2,277,000 (or $0.32 per fully diluted share) for the second fiscal quarter ended December 31, 2022. Net loss for the quarter ended December 31, 2023 was $3,075,000 (or a loss of $0.44 per fully diluted share) compared to net earnings of $1,951,000 (or $0.28 per fully diluted share) for the quarter ended December 31, 2022. The net loss for the quarter included a loss from discontinued operations of $2,668,000 (or a loss of $0.38 per fully di

SunLink Health Systems, Inc. (NYSE:AMERICAN) today announced that its indirect subsidiary, Southern Health Corporation of Houston, Inc. ("Southern"), has reached a revised agreement for the sale of Trace Regional Hospital and three (3) patient clinics in Chickasaw County, MS, ("Trace") to Progressive Health of Houston, LLC ("Progressive"). Southern sold certain personal and intangible property to Progressive for $500,000 pursuant to an asset purchase agreement, entered into a six-month net lease of certain hospital real property for $20,000 per month, and engaged Progressive under a management agreement to manage the operations of the hospital and clinics until receipt of certain regulatory

SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) today announced that SunLink and Progressive Health Group, LLC ("Progressive") have amended their previously-announced agreement for the sale by SunLink's subsidiary, Crown Healthcare Investments, LLC, of Trace Regional Medical Center in Houston, Mississippi, to Progressive to, among other things, extend the closing date until January 31, 2024, on substantially the same price and terms previously announced. SunLink Health Systems, Inc. is the parent company of subsidiaries that own and operate healthcare properties and businesses in the Southeast. Each of the Company's businesses is operated locally with a strategy of linking patients' n

SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2023 compared to a loss from continuing operations of $605,000 (or a loss of $0.09 per fully diluted share) for the first fiscal quarter ended September 30, 2022. On November 10, 2023, the Company's subsidiary, Crown Healthcare Investments, LLC, signed an agreement with Progressive Health Group, LLC, ("Buyer") for the sale of the subsidiary that owns and operates Trace Regional Medical Center ("Trace"), which includes a hospital, a skilled nursing facility and three (3) patient clinics in Houston,

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)